Prepared for S&P500 correction with Buying PUT option
Updated
I've closed every other position, staying in cash and
playing for SPX correction because:
1/ SP500 RSI falling down
2/ Strong trendline broken
3/ Selling Volume increased
My strategy is simple:
BUY SPY Jun30' 415 PUT for 3.85db, because VIX is realive low
SIZING: only a little of my CAP is used for this binary play.
Stop/my risk management: Closing immediately if daily candle is closing ABOVE the box, max loss in my calculations in this case could be 50% of position.
Take profit strategy: selling about ~38cr (x10).
Of course I'll not wait until expiry...!
If you liked this article, check my other ideas.
Anyway: HIT THE LIKE BUTTON BELOW, and for fresh option ideas FOLLOW ME( @mrAnonymCrypto ) on tradingview!
playing for SPX correction because:
1/ SP500 RSI falling down
2/ Strong trendline broken
3/ Selling Volume increased
My strategy is simple:
BUY SPY Jun30' 415 PUT for 3.85db, because VIX is realive low
SIZING: only a little of my CAP is used for this binary play.
Stop/my risk management: Closing immediately if daily candle is closing ABOVE the box, max loss in my calculations in this case could be 50% of position.
Take profit strategy: selling about ~38cr (x10).
Of course I'll not wait until expiry...!
If you liked this article, check my other ideas.
Anyway: HIT THE LIKE BUTTON BELOW, and for fresh option ideas FOLLOW ME( @mrAnonymCrypto ) on tradingview!
Trade closed: stop reached
Closed obviously.The nature of these hedging doesn't matter the loss, because next time the single put option's profit will absolutely cover it.
Boost up your charts with Options PRO!
REAL Options metrics for over 165+ liquid US symbols:
✔ 𝗔𝘂𝘁𝗼-𝗨𝗽𝗱𝗮𝘁𝗶𝗻𝗴 𝗚𝗘𝗫 𝗹𝗲𝘃𝗲𝗹𝘀
✔ IVRank ✔ CALL/PUT skew ✔ Volatility Skew ✔ Delta curves
👉 7-day TRIAL 🌐 TanukiTrade.com
REAL Options metrics for over 165+ liquid US symbols:
✔ 𝗔𝘂𝘁𝗼-𝗨𝗽𝗱𝗮𝘁𝗶𝗻𝗴 𝗚𝗘𝗫 𝗹𝗲𝘃𝗲𝗹𝘀
✔ IVRank ✔ CALL/PUT skew ✔ Volatility Skew ✔ Delta curves
👉 7-day TRIAL 🌐 TanukiTrade.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.